Phase II trial of CX 4945 in combination with erlotinib in patients with non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2011
At a glance
- Drugs Erlotinib; Silmitasertib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Jun 2011 New trial record